INOZYME

Serial Number 87344845
606

Registration Progress

Application Filed
Feb 22, 2017
Under Examination
Jan 2, 2018
Approved for Publication
Jul 11, 2017
Published for Opposition
Jul 11, 2017
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: INOZYME
Previous Owner: Inozyme Pharma, Inc.
Classes: 005

Trademark Image

INOZYME

Basic Information

Serial Number
87344845
Filing Date
February 22, 2017
Published for Opposition
July 11, 2017
Abandonment Date
February 8, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 8, 2021
Classes
005

Rights Holder

Inozyme Pharma, Inc.

03
Address
321 Summer Street, Suite 400
Boston, MA 02210

Ownership History

Inozyme Pharma, Inc.

Original Applicant
03
Cambridge, MA

Inozyme Pharma, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

43 events
Date Code Type Description Documents
Aug 19, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 19, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 19, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 19, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 19, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 8, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Feb 8, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 1, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 30, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 15, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 30, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 15, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 16, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 5, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 3, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 3, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 3, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 4, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 2, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 2, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 2, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 1, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 1, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 20, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 7, 2018 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 7, 2018 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 7, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 5, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 5, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 5, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 2, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 19, 2017 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Aug 3, 2017 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jul 11, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 11, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 21, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 26, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 17, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 28, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 25, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
therapeutic pharmaceutical for the diagnosis and treatment of diseases afflicting the bone, kidney and tissue; pharmaceutical products for use in the diagnosis and treatment of bone, kidney and tissue diseases

Classification

International Classes
005